Sign In
Buy BICX
$0.260
-0.0400 (-13.33%)
At Close: Jul 31, 2026
BioCorRx Acquires Intellectual Property for Drug Delivery
02:15pm, Monday, 22'nd Nov 2021 Intrado Digital Media
Patent Application Covers Solid Implant Formulation for Drug Delivery
BioCorRx to Present at the Q4 Investor Summit Conference on November 16th
02:47pm, Wednesday, 10'th Nov 2021
Anaheim, California--(Newsfile Corp. - November 10, 2021) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disor
BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant
08:30am, Thursday, 07'th Oct 2021
ANAHEIM, CA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use
BioCorRx to Present at LD Micro Main Event on Tuesday, October 12th
12:16pm, Wednesday, 29'th Sep 2021
ANAHEIM, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance us
BioCorRx Files Patent Application with USPTO for Naltrexone Implant
08:30am, Wednesday, 22'nd Sep 2021
ANAHEIM, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use di
SAN DIEGO, CA, and ANAHEIM, CA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedic
BioCorRx Provides Business Update for the Second Quarter of 2021
08:30am, Monday, 16'th Aug 2021
ANAHEIM, CA, Aug. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use
BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board
08:30am, Tuesday, 22'nd Jun 2021
ANAHEIM, CA, June 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc . (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment o
BioCorRx Provides Business Update for the First Quarter of 2021
09:05am, Tuesday, 18'th May 2021
ANAHEIM, CA, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc . (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment
BioCorRx Completes $2.25 Million Private Placement
09:24am, Tuesday, 02'nd Mar 2021
ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use
